|
1
|
Chitturi S, Farrell GC, Hashimoto E,
Saibara T, Lau GK and Sollano JD; Asia-Pacific Working Party on
NAFLD, : Non-alcoholic fatty liver disease in the Asia-Pacific
region: Definitions and overview of proposed guidelines. J
Gastroenterol Hepatol. 22:778–787. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Milić S and Stimac D: Nonalcoholic fatty
liver disease/steatohepatitis: Epidemiology, pathogenesis, clinical
presentation and treatment. Dig Dis. 30:158–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma Z, Chu L, Liu H, Li J, Zhang Y, Liu W,
Dai J, Yi J and Gao Y: Paeoniflorin alleviates non-alcoholic
steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway.
Int Immunopharmacol. 38:377–384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katsiki N, Perez-Martinez P, Anagnostis P,
Mikhailidis DP and Karagiannis A: Is nonalcoholic fatty liver
disease indeed the hepatic manifestation of metabolic syndrome?
Curr Vasc Pharmacol. 16:219–227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Angulo P, Alba LM, Petrovic LM, Adams LA,
Lindor KD and Jensen MD: Leptin, insulin resistance, and liver
fibrosis in human nonalcoholic fatty liver disease. J Hepatol.
41:943–949. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bellentani S and Marino M: Epidemiology
and natural history of non-alcoholic fatty liver disease (NAFLD).
Ann Hepatol. 8 (Suppl 1):S4–S8. 2009.PubMed/NCBI
|
|
7
|
Day CP and James OF: Steatohepatitis: A
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michelotti GA, Machado MV and Diehl AM:
NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol.
10:656–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen LL and Yang L: Regulation of circRNA
biogenesis. RNA Biol. 12:381–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vicens Q and Westhof E: Biogenesis of
circular RNAs. Cell. 159:13–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li TR, Jia YJ, Wang Q, Shao XQ and Lv RJ:
Circular RNA: A new star in neurological diseases. Int J Neurosci.
127:726–734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu H, Guo S, Li W and Yu P: The circular
RNA Cdr1as, via miR-7 and its targets, regulates insulin
transcription and secretion in islet cells. Sci Rep. 5:124532015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan X, Weng X, Zhao Y, Chen W, Gan T and
Xu D: Circular RNAs in cardiovascular disease: An overview. Biomed
Res Int. 2017:51357812017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Z, Li X, Jian D, Hao P, Rao L and Li
M: Hsa_circ_0054633 in peripheral blood can be used as a diagnostic
biomarker of pre-diabetes and type 2 diabetes mellitus. Acta
Diabetol. 54:237–245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao T, Chen Q, Fu L and Guo J: Circular
RNAs: Biogenesis, properties, roles, and their relationships with
liver diseases. Hepatol Res. 47:497–504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shang X, Li G, Liu H, Li T, Liu J, Zhao Q
and Wang C: Comprehensive circular RNA profiling reveals that
hsa_circ_0005075, a new circular RNA biomarker, is involved in
hepatocellular crcinoma development. Medicine (Baltimore).
95:e38112016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Guo J, Chen Y, Chang C and Xu C:
Comprehensive CircRNA expression profile and selection of key
CircRNAs during priming phase of rat liver regeneration. BMC
Genomics. 18:802017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao Z, Luo J, Hu K, Lin J, Huang H, Wang
Q, Zhang P, Xiong Z, He C, Huang Z, et al: ZKSCAN1 gene and its
related circular RNA (circZKSCAN1) both inhibit hepatocellular
carcinoma cell growth, migration, and invasion but through
different signaling pathways. Mol Oncol. 11:422–437. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen YJ, Zhu JM, Wu H, Fan J, Zhou J, Hu
J, Yu Q, Liu TT, Yang L, Wu CL, et al: Circulating microRNAs as a
fingerprint for liver cirrhosis. PLoS One. 8:e665772013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin X, Feng CY, Xiang Z, Chen YP and Li
YM: CircRNA expression pattern and circRNA-miRNA-mRNA network in
the pathogenesis of nonalcoholic steatohepatitis. Oncotarget.
7:66455–66467. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cardiff RD, Miller CH and Munn RJ: Manual
hematoxylin and eosin staining of mouse tissue sections. Cold
Spring Harb Protoc. 2014:655–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo XY, He CX, Wang YQ, Sun C, Li GM, Su
Q, Pan Q and Fan JG: Circular RNA profiling and bioinformatic
modeling identify its regulatory role in hepatic steatosis. Biomed
Res Int. 2017:59361712017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y, Yuan B, Wu Z, Dong Y, Zhang L and
Zeng Z: Microarray profiling of circular RNAs and the potential
regulatory role of hsa_circ_0071410 in the activated human hepatic
stellate cell induced by irradiation. Gene. 629:35–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haczeyni F, Yeh MM, Ioannou GN, Leclercq
IA, Goldin R, Dan YY, Yu J, Teoh NC and Farrell GC: Mouse models of
non-alcoholic steatohepatitis: A reflection on recent literature. J
Gastroenterol Hepatol. 33:1312–1320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rinella ME, Elias MS, Smolak RR, Fu T,
Borensztajn J and Green RM: Mechanisms of hepatic steatosis in mice
fed a lipogenic methionine choline-deficient diet. J Lipid Res.
49:1068–1076. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Zhu K, Yu W, Wang H, Liu L, Wu Q,
Li S and Guo J: MiR-181b regulates steatosis in nonalcoholic fatty
liver disease via targeting SIRT1. Biochem Biophys Res Commun.
493:227–232. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li M, Hong W, Hao C, Li L, Wu D, Shen A,
Lu J, Zheng Y, Li P and Xu Y: SIRT1 antagonizes liver fibrosis by
blocking hepatic stellate cell activation in mice. FASEB J.
32:500–511. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang B, Li W, Guo K, Xiao Y, Wang Y and
Fan J: miR-181b promotes hepatic stellate cells proliferation by
targeting p27 and is elevated in the serum of cirrhosis patients.
Biochem Biophys Res Commun. 421:4–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu F, Lu Z, Chen B, Dong P and Zheng J:
Identification of a novel lincRNA-p21-miR-181b-PTEN signaling
cascade in liver fibrosis. Mediators Inflamm. 2016:98565382016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu L, Wang J, Lu H, Zhang G, Liu Y, Wang
J, Zhang Y, Shang H, Ji H, Chen X, et al: MicroRNA-130a and −130b
enhance activation of hepatic stellate cells by suppressing PPARγ
expression: A rat fibrosis model study. Biochem Biophys Res Commun.
465:387–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
